 Hello, hello, how's everybody doing today? This is rich from rich TV live, and we have some breaking news for you today Breaking news for you today here live on rich TV live. Hope you all had a great weekend and We have some breaking news for you today and Yeah, been an interesting weekend lots of things happening and the markets just Been under a lot of selling pressure right market's been under a lot of selling pressure the stock market's been under selling pressure The cryptocurrency markets been under selling pressure and we've got some news for you today So thank you guys for joining us if you like the video Please smash the like button comment down below share the video everywhere and subscribe if you're learning how to trade You can join us at richpigsdaily.com and you can learn how to trade stocks and crypto currencies Obviously has been a tough for market recently markets coming back from all-time highs in both the stock market and the cryptocurrency market So there is incredible opportunities in my opinion in the market right now for those that understand How to find them? So let's talk about the news that is breaking news this morning breaking news this morning alright, so The big news that I want to break to you today is from Pharmathare Pharmathare announces FDA approval of ketamine. That's right. Finally. We've been waiting for this We've been waiting for pharmacare to get their FDA approval and they've got it Finally now getting the FDA approval of ketamine ind in the treatment of Parkinson's disease This is breaking news big breaking news from Pharmathare breaking this morning the symbol for pharmacare is PHRM in Canada the symbol for pharmacare in America is PHRRF That's a symbol for pharmacare if you guys like the video, please smash the like button comment down below share the video everywhere and subscribe Good morning, Steven. Good morning, Amjad Hope you all have a good morning. Hope you're ready for a big week Obviously markets have been tougher recently and this is where Investors get paid Everybody wants to buy stocks and buy cryptos when the market's high, but that's not the way to trade You want to buy when they're down? But people get scared when they're down because they're down so they don't want to dump any more money into the market Well when stocks are down, that's when we're buying when when stocks are down We buy the dips and when stocks are up. We're selling. We're taking our profits. So This is really where Investors make their money in markets like this. So let's talk a little bit about pharma there holdings limited Pharmathare announces FDA approval of ketamine IND in the treatment of Parkinson's disease. This is big breaking news. I'm literally breaking this news to you first So pharma there a psychedelics biotech company now remember psychedelics have been under a lot of selling pressure be aware of that Okay, it's not a super hot sector right now when I do these videos They're strictly for information and education purposes Please do your due diligence do your research before you invest in anything that we talk about here on rich TV live Okay, and what I'd like to do is open the discussion to know what you guys think about this news Do you think that this is a company that has potential? Do you think that long-term? They've got a chance to be successful Obviously, this is big news that they have announced FDA approval of ketamine IND in the treatment of Parkinson's disease Do you know anyone that's suffering from Parkinson's disease? How much has that affected their life and could this be a game-changer? So Pharmathare is a psychedelics biotech company pleased to announce the US Food and Drug Administration FDA has approved the company's Investigational new drug IND application to pursued with a phase two clinical trial to evaluate the safety efficacy and pharma pharma cauconetics of ketamine in the treatment of levodopa induced dyskinesia in patients with Parkinson's disease LID-PD Pharmathare expects to begin enrolling patients in the phase two clinical trial in Q3 2021 Assuming the phase two clinical trial is positive The company will request a meeting with the FDA to discuss its plan and obtain an agreement to move into phase three clinical study under 505b to regulatory pathway next year Big breaking news. What do you think of this news and like I said to you guys about pharmaceuticals and about Psychedelic stocks. They're early. We're early to the party, right? They're two years away from having revenue But some of these companies that we've been talking about are going to absolutely explode just like mind medicine did Mind medicine went up over a thousand percent after we brought it to you first and for the first six months They didn't trade very well. They were stuck for six months And they didn't even move and then all of a sudden out of nowhere they exploded So at the very least what you want to do with these companies put them on your watch list put them on your radar, okay? Fabio Cianelli who we've had on our show chief executive officer of Pharmathare said The FDA's acceptance of our IND application for ketamine to treat Parkinson's disease is a significant milestone for us The FDA IND is our first of many we will aim to obtain and we're one of a few psychedelic focused Biotech companies that have an IND approved for the FDA for a recognized psychedelic drug the IND paves the way for us to expediously evaluate ketamine and other psychedelics via the FDA regulatory pathway in various mental illness Neurological and pain disorders. We are committed to building a rich product pipeline of novel uses Formulations and delivery methods of psychedelics and with our FDA IND in place We now have the foundation in making Pharmathare a global leader in psychedelic based therapeutics And like I said, we're early to the party This is just the beginning for Pharmathare and this is just the beginning for psychedelics Parkinson's disease is a debilitating disorder that affects over 1 million people in the US and more than 7 million people worldwide There is currently no cure for Parkinson's disease Although some drug combinations are used to treat the disease symptoms the global Parkinson's disease market is expected to grow from USD 5 billion in 2019 to USD 7.5 billion by the end of 2025 So that's huge growth potential folks and is estimated that the potential market opportunity for lid dash PD to be over 3 billion USD in the US alone. Wow This is a huge market opportunity folks and you guys are getting a chance to learn about it first About phase 2 clinical trials the clinical trial is titled a multi-center phase 2 randomized double-blind Perspective active placebo controlled trial of sub anesthetic ketamine to treat Levodopa dash induced Diskincia in subjects with Parkinson's disease It is anticipated that up to eight clinical sites in the US will randomize a total of up to 36 subjects to the investigational product ketamine or active control Mitazolam the primary endpoint of the study is the change in the united in the unified diskincia rating scale Udy srs total score from baseline to week eight secondary endpoints of the study include the change in total objective scores of the Udy srs total daily off times as Assessed by subjects completed 24-hour diaries and change in the UP DRS total and some scores of Motor and diskincia from baseline to week eight because lid can marked affected a lid can markedly affect a Parkinson's patients every day activities a Reduction in lid could improve the patient's quality of life. It's a game changer I mean what these guys are doing is absolute game changing and it's important that we're identifying undervalued underappreciated underexposed Opportunities before anybody else in the world and I'd love to know your opinion. The company has assembled a prolific scientific and clinical experienced Team in Parkinson's disease including Dr. Scott Sherman and Dr. Torsten Falk from the University of Arizona Dr. Alberto Espe from the University of Cincinnati and Dr. Robert Houser from the University of South Florida So what is the ketamine potential in Parkinson's disease? Ketamine is an FDA approved N methanol D aspirate NMDA Receptor-moduling drug that is widely used and as an aesthetic agent either alone or in combination with other anesthetic agents The possible therapeutic effects of low-dose ketamine on lid was noted in a retrospective analysis of PD patients Who received ketamine for pain relief? During this analysis it was observed that the patient's experience in improvement in lid lasting several weeks beyond treatment These results were corroborated in a test of low-dose ketamine in a rodent lid model And this positive effect has been examined in a controlled study Ketamine may also have additional benefits in the treatment of pain and depression which are frequent frequent in Parkinson's disease about Parkinson's disease so Parkinson's disease is terrible and I've known people that have had it and Really destroys their life. It affects their life. I'm not gonna say it destroys their life, but it affects their life in so many ways They almost have split personalities. It's um It's it's terrible. There is currently no cure for Parkinson's disease, although the Ideology of Parkinson's disease is not fully understood. It is thought to result from a loss of pigmented Dopamine ergic neurons in the substantia and nigra and their stradal projections leading to dopamine deficiency in the Stradium this ultimately affects the corticostridal system that controls movement as a progressive neurogenetic disorder of the Central nervous system that primarily affects the motor nerve system symptoms of Parkinson's disease may emerge slowly and include tremors rigidity Brady kinsia and Postero instability Also patients may experience non-motor symptoms such as autumnic dysfunction orthostatic hypertension constipation bladder dysfunction psychiatric depression Cognitive and sensory symptoms pain, I mean there's a long list of of Really negative effects of Parkinson's disease So what these guys are doing is making a world of difference and live in a world where we need more People doing something to make a difference these non-motor symptoms become more common as the disease progresses treatments including levodopa and dopamine agonists Which restore the dopamine deficits in the brain have been employed for almost 50 years However with continued treatment using levodopa dose-limiting motor side effects often emerge This includes the emergence of abnormal involuntary movements termed levodopa induced Diskinsias which can be identified in about 50% of patients within five years after Initiation of levodopa treatment and in almost all patients within 10 years post treatment initiation these side effects often limit further dose increases in Dopaminurgic therapy There can be no assurance that the FDA will support any potential request for an expedited path to approval or further development for ketamine in the treatment of Parkinson's disease About pharma there holdings so the symbol for pharma there in Canada is PHRM and the symbol in America is PHRRF Pharma there holdings limited is a psychedelics biotech company focused on the research development and commercialization of ketamine and novel Micronetal patches for the delivery of psychedelics to treat mental illness Neurological and pain disorders love to know what you guys think what do you guys think of this news? This is the big breaking news, and I'm breaking to you this morning Love to know what you guys think love to know what your guys opinion is on the news Good morning, everybody. I'm gonna show you guys messages here Good to have you all here Happy morning Phil. Hope you're ready for a big week Obviously the markets have been really really difficult over the last few weeks. I'm not suggesting that it's been easy The stock market is not for the faint of heart and typically when the markets are down that's the best time to buy and When the markets are up, it's the best time to lock in profits So I think right now more than ever it's important to really know what you're investing in get to know every company Watch the markets watch the news watch the overall markets watch the trends of the stocks that you're investing in and Really make sure that you're investing in companies that you believe in long term Because when the markets start to sell off or trade sideways or start having volatility Those are really the best times to buy you want to buy when stocks are down and right now There's a lot of stocks, especially small caps that are down. So there's a lot of opportunities disguised in Really disguised in an aggressive selling so that aggressive selling is going to be an incredible buying opportunity for the right investor I'm not suggesting that you go and invest all your money in this stock But I'd love to at least have the conversation and at least make you aware of the news. What do you guys think? Sam says well, you always prepare us for this type of market never let your profit go away So kind of ready good. Yeah, I mean, this is what we talk about, right by the dips sell the rips We know that red is coming typically red fall is green and we've been at all-time highs So when you're at all-time highs in the markets, you have to assume that there's gonna be a pullback Same things happen in cryptocurrency Cryptocurrencies hit all-time highs Cryptocurrencies are having a pullback too. So nothing new with Investments coming back from all-time highs In fact, if investments just kept going up forever and never came down, then I'd be concerned or I'd be worried But when you see investments go up and then come down That's a buying opportunity so they can go up again Just remember how it feels when you're down right now so that when they do go up You can lock in your games because nothing goes up forever. Even Tesla has come back from their earlier Gains of last year where they were one of the hottest stocks in the world and so far this year if you had bought Tesla in January, you're down so if the biggest and the best companies are down in 2021 then you have to assume that smaller companies will also be down and In my opinion the reason why this is happening. Yes Skylight is uplifting to the Nasdaq absolutely So that will be a catalyst for skylight and there's other companies that we're looking at that are also uplifting to the Nasdaq like tat Like the Cindy Motors Corp like hut So there's a few other companies that we're watching mind medicine just recently went to the Nasdaq so there's quite a few companies that we're watching very carefully that will be uplifting there's catalyst coming and Small cap season is typically between September and January So between September and January we fully expect to have another massive small cap run But what's gonna happen between now and then so there's gonna be opportunities to present ourselves in the best companies I would say over the next four months This is the best time to position ourselves in some of the best companies dividend stocks small cap stocks You name it. There's going to be opportunities disguised in blood in this market And for those that can stomach it that have what it takes to be able to stomach the red this is the best time to buy and When they go up again and they explode Remember what it feels like when the market's down and make sure you lock in your gains Make sure you lock in your gains and you're building your vault building your treasury building your account That's the most important thing. Don't fall in love with stocks because when stocks go down They're not going to give you your money back Right, so there's no reason to fall in love with them. Okay, and when you fall in love with them and you hold through the Volatility sometimes you stop fall you stop loving them, right? And then what happens is people typically start to sell in the red. Well, that's not my strategy My strategy is I'm gonna be buying when things are down I'm gonna do the research do the due diligence look for growing companies Buy when the stocks are down and then when they're up and everybody's talking about it Like when you hop in an uber and your ubers talking about your pick and you hop in a cab and your calves talk about your pick And then you turn on the radio and they're talking about your pick. That's when you want to be locking in gains Right, you want to be locking in gains when everything's at the top, right? And focus on building your vault fall in love with building your vault Don't fall in love with specific companies. That's my best advice for you guys If you guys would like to learn how to trade you can join our club at richpigsdaily.com Left to have you we're trading stocks and crypto currencies 24 hours a day seven days a week It's been a wild ride lots of volatility in the markets We've had a huge start to the year Lots of gains were taken and now people are taking those gains in both the stock market and the crypto space So you need to be aware of the trend right now the trend has been sideways or down that's been the trend overall in the markets and That is the same trend in cryptos as well. So Left to know what you guys think about this news and this pick Farmer there huge huge huge news. What do you guys think? Hope you guys have a great trading day. The markets are now opening. I'll let you guys go What do you guys think about the big news from? pharma there, which we broke to you guys first once again pharma there announces FDA approval of ketamine ind in the treatment of Parkinson's disease symbol for pharma there phrm in Canada and phrf in America Thank you guys for watching if you're not winning. You're not watching. We bring you the winners and we bring them to first Have a great day everybody. It's your boy rich from rich to be live and I'm out peace